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Background
Over a three-year period (2002–2004), we have per-
formed 312 constant rate normal saline infusion studies
in 197 patients with CSF shunts inserted to treat varying
types of hydrocephalus. The data has been analysed retro-
spectively with two main objectives: 1. To investigate
which parameters describing CSF dynamics correlate with
the clinical finding of shunt malfunction (under drainage
or over drainage). 2. To estimate accuracy of this method.
Materials and methods
A constant rate infusion of normal saline was performed
into the shunt prechamber or previously implanted
Ommaya reservoir. The CSF pressure and arterial pressure
(from Finapress finger cuff) were monitored continuously
during 10 minutes of baseline recording and during the
infusion in 99 tests. CSF compensatory parameters, steady
state pressure levels, cerebrovascular pressure reactivity
and vasogenic waveforms of CSF pressure were calculated
Results
In 161 of the 312 infusion tests results indicated under
draining shunts. Patients with under draining shunts had
higher baseline and plateau CSF pressures, higher resist-
ance to CSF outflow and higher levels of baseline respira-
tory and pulse amplitude waveforms. A significantly
greater increase in intensity of vasogenic waves during the
test was seen in cases where shunts were under draining.
In 21 patients who underwent operative revision of the
shunt, reports of intraoperative shunt assessment were
available in patients' notes. Shunt malfunction was con-
firmed at surgery in 19 cases. None of the patients in
whom shunt was assessed as patent were admitted to hos-
pital with symptoms of acute intracranial hypertension
within subsequent 2 weeks. There was no increase in com-
plications related to the performance of the constant rate
infusion of normal saline.
Conclusion
Shunt testing in-vivo to detect malfunction and under
drainage by a constant rate infusion of normal saline is
easy, safe, clinically useful and has satisfactory positive
prediction power (estimated 90%).
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